Guys, I'm like all of you, the share price increase over the last few days has been amazing. I'm surprised ACR hasn't had a "speeding ticket". Its hard to believe this SP increase is because of an announcement of another partner company even though Axiron appears to be the driver of the increased interest.
I'm wondering if one of the US or European pharmaceutical giants is taking more than a cursory look.
Add to My Watchlist
What is My Watchlist?
